Genomic insights into low-level rifampicin resistance mediated by borderline <i>rpoB</i> mutations in <i>Mycobacterium tuberculosis</i>: prevalence and phylogeny in Northeast China. [PDF]
Li L +8 more
europepmc +1 more source
Insights Into Urogenital Tuberculosis: Impact of Microbiological Diagnosis. [PDF]
Bala K +4 more
europepmc +1 more source
Europe's failure to deliver on drug-resistant tuberculosis. [PDF]
The Lancet Regional Health-Europe.
europepmc +1 more source
Epidemiological Characteristics and Spatiotemporal Cluster Analysis of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis Among Older People - China, 2019-2025. [PDF]
Li Y +5 more
europepmc +1 more source
Rare emergence of delamanid resistance in multidrug-/rifampicin-resistant tuberculosis patients receiving delamanid-containing regimens: a prospective multicentric study in China. [PDF]
Shu W +15 more
europepmc +1 more source
Anaemia, hypoalbuminemia, and risk of cycloserine-associated neuropsychiatric toxicity in a shortened oral regimen for multidrug/rifampicin-resistant TB. [PDF]
Shen EQL +13 more
europepmc +1 more source
Diagnostic Discordance During MDR-TB Treatment: Retrospective Identification of <i>Mycobacterium avium Complex</i>-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing. [PDF]
Rukasha I +9 more
europepmc +1 more source
Burden of multidrug-resistant and extensively drug-resistant tuberculosis in China, India and Russia: estimates from the GBD 2023 study. [PDF]
Li JD +10 more
europepmc +1 more source
Contezolid in the Treatment of Multidrug-Resistant Tuberculous Meningitis: A Case Report. [PDF]
Wang N +10 more
europepmc +1 more source

